Toll Free: 1-888-928-9744
Published: Apr, 2017 | Pages:
85 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Anesthetic Effect - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anesthetic Effect - Pipeline Review, H1 2017, provides an overview of the Anesthetic Effect (Central Nervous System) pipeline landscape. Anesthetic effect causes a loss of consciousness. The factors that can increase risk of complications include smoking, obstructive sleep apnea, obesity, high blood pressure, history of adverse reactions to anesthesia and drug allergies. Report Highlights Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Anesthetic Effect - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Anesthetic Effect (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The Anesthetic Effect (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Anesthetic Effect and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 3, 2, 1, 3, 15, 1 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively. Anesthetic Effect (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data. Scope - The pipeline guide provides a snapshot of the global therapeutic landscape of Anesthetic Effect (Central Nervous System). - The pipeline guide reviews pipeline therapeutics for Anesthetic Effect (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources. - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. - The pipeline guide reviews key companies involved in Anesthetic Effect (Central Nervous System) therapeutics and enlists all their major and minor projects. - The pipeline guide evaluates Anesthetic Effect (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. - The pipeline guide encapsulates all the dormant and discontinued pipeline projects. - The pipeline guide reviews latest news related to pipeline therapeutics for Anesthetic Effect (Central Nervous System) Reasons To Buy - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies. - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. - Find and recognize significant and varied types of therapeutics under development for Anesthetic Effect (Central Nervous System). - Classify potential new clients or partners in the target demographic. - Develop tactical initiatives by understanding the focus areas of leading companies. - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics. - Formulate corrective measures for pipeline projects by understanding Anesthetic Effect (Central Nervous System) pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 Introduction 5 Global Markets Direct Report Coverage 5 Anesthetic Effect - Overview 6 Anesthetic Effect - Therapeutics Development 7 Pipeline Overview 7 Pipeline by Companies 8 Pipeline by Universities/Institutes 10 Products under Development by Companies 11 Products under Development by Universities/Institutes 13 Anesthetic Effect - Therapeutics Assessment 14 Assessment by Target 14 Assessment by Mechanism of Action 16 Assessment by Route of Administration 18 Assessment by Molecule Type 20 Anesthetic Effect - Companies Involved in Therapeutics Development 21 4P Therapeutics LLC 21 Biolab Farmaceutica Ltda 21 Drawbridge Pharmaceuticals Pty Ltd 22 Expanesthetics Inc 22 Jiangsu Hengrui Medicine Co Ltd 23 Lee's Pharmaceutical Holdings Ltd 23 Lipicard Technologies Ltd 24 NanoMedex Pharmaceuticals Inc 24 Paion AG 25 Phosphagenics Ltd 25 Physica Pharma 26 Primex Pharmaceuticals Oy 26 Proteus SA 27 Sphaera Pharma Pvt Ltd 27 Taiwan Liposome Company Ltd 28 The Medicines Company 29 WEX Pharmaceuticals Inc 29 Anesthetic Effect - Drug Profiles 30 alphaxalone - Drug Profile 30 bupivacaine hydrochloride SR - Drug Profile 32 Carboetomidate - Drug Profile 33 gabafol - Drug Profile 34 HSK-3486 - Drug Profile 35 lidocaine hydrochloride - Drug Profile 36 lidocaine hydrochloride - Drug Profile 37 LT-1121 - Drug Profile 38 LT-1123 - Drug Profile 39 MDCO-700 - Drug Profile 40 Methoxycarbonyl Carboetomidate - Drug Profile 42 Methoxycarbonyl Etomidate - Drug Profile 43 midazolam hydrochloride - Drug Profile 45 neosaxitoxin - Drug Profile 46 PB-5109 - Drug Profile 48 PHY-301 - Drug Profile 49 propofol - Drug Profile 50 propofol - Drug Profile 51 propofol - Drug Profile 52 remimazolam - Drug Profile 53 remimazolam - Drug Profile 60 Small Molecule for General Anesthetic Effect - Drug Profile 61 Small Molecules for General Anesthetic Effect - Drug Profile 62 Small Molecules to Inhibit NMDA Receptor for Anesthesia - Drug Profile 63 SPR-819 - Drug Profile 64 Tetrodotoxin - Drug Profile 65 TLC-590 - Drug Profile 67 Anesthetic Effect - Dormant Projects 68 Anesthetic Effect - Discontinued Products 69 Anesthetic Effect - Product Development Milestones 70 Featured News & Press Releases 70 Appendix 82 Methodology 82 Coverage 82 Secondary Research 82 Primary Research 82 Expert Panel Validation 82 Contact Us 82 Disclaimer 83
List of Tables
Number of Products under Development for Anesthetic Effect, H1 2017 Number of Products under Development by Companies, H1 2017 Number of Products under Development by Universities/Institutes, H1 2017 Products under Development by Companies, H1 2017 Products under Development by Companies, H1 2017 (Contd..1), H1 2017 Products under Development by Universities/Institutes, H1 2017 Number of Products by Stage and Target, H1 2017 Number of Products by Stage and Mechanism of Action, H1 2017 Number of Products by Stage and Route of Administration, H1 2017 Number of Products by Stage and Molecule Type, H1 2017 Anesthetic Effect - Pipeline by 4P Therapeutics LLC, H1 2017 Anesthetic Effect - Pipeline by Biolab Farmaceutica Ltda, H1 2017 Anesthetic Effect - Pipeline by Drawbridge Pharmaceuticals Pty Ltd, H1 2017 Anesthetic Effect - Pipeline by Expanesthetics Inc, H1 2017 Anesthetic Effect - Pipeline by Jiangsu Hengrui Medicine Co Ltd, H1 2017 Anesthetic Effect - Pipeline by Lee's Pharmaceutical Holdings Ltd, H1 2017 Anesthetic Effect - Pipeline by Lipicard Technologies Ltd, H1 2017 Anesthetic Effect - Pipeline by NanoMedex Pharmaceuticals Inc, H1 2017 Anesthetic Effect - Pipeline by Paion AG, H1 2017 Anesthetic Effect - Pipeline by Phosphagenics Ltd, H1 2017 Anesthetic Effect - Pipeline by Physica Pharma, H1 2017 Anesthetic Effect - Pipeline by Primex Pharmaceuticals Oy, H1 2017 Anesthetic Effect - Pipeline by Proteus SA, H1 2017 Anesthetic Effect - Pipeline by Sphaera Pharma Pvt Ltd, H1 2017 Anesthetic Effect - Pipeline by Taiwan Liposome Company Ltd, H1 2017 Anesthetic Effect - Pipeline by The Medicines Company, H1 2017 Anesthetic Effect - Pipeline by WEX Pharmaceuticals Inc, H1 2017 Anesthetic Effect - Dormant Projects, H1 2017 Anesthetic Effect - Discontinued Products, H1 2017
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.